Biocon Biologics Secures Market Entry for Biosimilar Bmab 1200 in Multiple Countries with Janssen Agreement Aug. 29, 2024, 8:15 a.m. Biocon Biologics Ltd (BBL) has signed a settlement and license agreement with Janssen Biotech Inc., Janssen Sciences Ireland, and Johnson & Johnson.This agreement allows Biocon Biolo… Unlock the Full Filing And Lot More Access premium insights and stay ahead of the market with Dzambhala Pro. Learn More